Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spero Therapeutics (SPRO) Change in Taxes (2023 - 2025)

Spero Therapeutics' Change in Taxes history spans 3 years, with the latest figure at $220000.0 for Q4 2025.

  • For Q4 2025, Change in Taxes rose 185.71% year-over-year to $220000.0; the TTM value through Dec 2025 reached $7000.0, changed N/A, while the annual FY2025 figure was $209000.0, 198.12% up from the prior year.
  • Change in Taxes reached $220000.0 in Q4 2025 per SPRO's latest filing, up from $77000.0 in the prior quarter.
  • In the past five years, Change in Taxes ranged from a high of $220000.0 in Q4 2025 to a low of -$1.8 million in Q4 2023.
  • Average Change in Taxes over 3 years is -$454250.0, with a median of -$106500.0 recorded in 2024.
  • Peak YoY movement for Change in Taxes: skyrocketed 104.22% in 2024, then soared 185.71% in 2025.
  • A 3-year view of Change in Taxes shows it stood at -$1.8 million in 2023, then skyrocketed by 104.22% to $77000.0 in 2024, then skyrocketed by 185.71% to $220000.0 in 2025.
  • Per Business Quant, the three most recent readings for SPRO's Change in Taxes are $220000.0 (Q4 2025), $77000.0 (Q4 2024), and -$290000.0 (Q3 2024).